Leptin Augments Proliferation of Breast Cancer Cells via Transactivation of HER2

Journal of Surgical Research

Volumn 149, Issue 1, 2008, Pages 9-14

  Soma, Daisuke ^a   Kitayama, Joji ^a   Yamashita, Hiroharu ^a   Miyato, Hideyo ^a   Ishikawa, Makoto ^a   Nagawa, Hirokazu ^a  

^a THE UNIVERSITY OF TOKYO   (Japan)

Author keywords

breast cancer; Her2; leptin; transactivation

Indexed keywords

4 (3 CHLOROANILINO) 6,7 DIMETHOXYQUINAZOLINE; 5 (2 BENZOTHIAZOLYL)THIOMETHYL 4 HYDROXY 3 METHOXYBENZYLIDENECYANOACETAMIDE; EPIDERMAL GROWTH FACTOR RECEPTOR 2; LEPTIN RECEPTOR; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; N BENZYL 2 CYANO 3 (3,4 DIHYDROXYPHENYL)ACRYLAMIDE; RECOMBINANT LEPTIN;

ARTICLE; BREAST CANCER; CANCER CELL; CELL PROLIFERATION; CONTROLLED STUDY; ENZYME ACTIVATION; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION; TRANSACTIVATION; WESTERN BLOTTING;

BREAST NEOPLASMS; CELL PROLIFERATION; FEMALE; GENES, ERBB-2; HORMONES; HUMANS; LEPTIN; PHOSPHORYLATION; RECEPTORS, LEPTIN; TRANS-ACTIVATION (GENETICS); TUMOR CELLS, CULTURED;

EID: 48949091209     PISSN: 00224804     EISSN: 10958673     Source Type: Journal    
DOI: 10.1016/j.jss.2007.10.012     Document Type: Article

References (54)

1. Calle E.E., Rodriguez C., Walker-Thurmond K., et al. Overweight, obesity, and mortality from cancer in a prospectively studied cohort of U.S. adults. N Engl J Med 348 (2003) 1625
2. Calle E.E., and Kaaks R. Overweight, obesity, and cancer: Epidemiological evidence and proposed mechanisms. Nat Rev Cancer 4 (2004) 579
3. Vigneri P., Frasca F., Sciacca L., et al. Obesity and cancer. Nutr Metab Cardiovasc Dis 16 (2006) 1
4. Folsom A.R., Kaye S.A., Prineas R.J., et al. Increased incidence of carcinoma of the breast associated with abdominal adiposity in postmenopausal women. Am J Epidemiol 131 (1990) 794
5. Morimoto L.M., White E., Chen Z., et al. Obesity, body size, and risk of postmenopausal breast cancer: The Women's Health Initiative (United States). Cancer Causes Control 13 (2002) 741
6. Sellers T.A., Kushi L.H., Potter J.D., et al. Effect of family history, body-fat distribution, and reproductive factors on the risk of postmenopausal breast cancer. N Engl J Med 326 (1992) 1323
7. Simpson E.R. Sources of estrogen and their importance. J Steroid Biochem Mol Biol 86 (2003) 225
8. Ahima R.S., and Flier J.S. Adipose tissue as an endocrine organ. Trends Endocrinol Metab 11 (2000) 327
9. Matsuzawa Y. Adipocytokines and metabolic syndrome. Semin Vasc Med 5 (2005) 34
10. Zhang Y., Proenca R., Maffei M., et al. Positional cloning of the mouse obese gene and its human homologue. Nature 372 (1994) 425
11. Collins S., Kuhn C.M., Petro A.E., et al. Role of leptin in fat regulation. Nature 380 (1996) 677
12. Henson M.C., and Castracane V.D. Leptin in pregnancy. Biol Reprod 63 (2000) 1219
13. Harris R.B. Leptin-much more than a satiety signal. Annu Rev Nutr 20 (2000) 45
14. Zhang F., Chen Y., Heiman M., et al. Leptin: Structure, function and biology. Vitam Horm 71 (2005) 345
15. Tartaglia L.A., Dembski M., Weng X., et al. Identification and expression cloning of a leptin receptor, OB-R. Cell 83 (1995) 1263
16. Hoggard N., Mercer J.G., Rayner D.V., et al. Localization of leptin receptor mRNA splice variants in murine peripheral tissues by RT-PCR and in situ hybridization. Biochem Biophys Res Commun 232 (1997) 383
17. Emilsson V., Liu Y.L., Cawthorne M.A., et al. Expression of the functional leptin receptor mRNA in pancreatic islets and direct inhibitory action of leptin on insulin secretion. Diabetes 46 (1997) 313
18. Glasow A., Haidan A., Hilbers U., et al. Expression of Ob receptor in normal human adrenals: Differential regulation of adrenocortical and adrenomedullary function by leptin. J Clin Endocrinol Metab 83 (1998) 4459
19. Tsuchiya T., Shimizu H., Horie T., et al. Expression of leptin receptor in lung: Leptin as a growth factor. Eur J Pharmacol 365 (1999) 273
20. Mix H., Widjaja A., Jandl O., et al. Expression of leptin and leptin receptor isoforms in the human stomach. Gut 47 (2000) 481
21. Laud K., Gourdou I., Pessemesse L., et al. Identification of leptin receptors in human breast cancer: Functional activity in the T47-D breast cancer cell line. Mol Cell Endocrinol 188 (2002) 219
22. Hu X., Juneja S.C., Maihle N.J., et al. Leptin-a growth factor in normal and malignant breast cells and for normal mammary gland development. J Natl Cancer Inst 94 (2002) 1704
23. Ishikawa M., Kitayama J., and Nagawa H. Enhanced expression of leptin and leptin receptor (OB-R) in human breast cancer. Clin Cancer Res 10 (2004) 4325
24. Harris R.C., Chung E., and Coffey R.J. EGF receptor ligands. Exp Cell Res 284 (2003) 2
25. Roskoski Jr. R. The ErbB/HER receptor protein-tyrosine kinases and cancer. Biochem Biophys Res Commun 319 (2004) 1
26. Slamon D.J., Godolphin W., Jones L.A., et al. Studies of the HER-2/neu proto-oncogene in human breast and ovarian cancer. Science 244 (1989) 707
27. Lohrisch C., and Piccart M. An overview of HER2. Semin Oncol 28 (2001) 3
28. Ross J.S., Fletcher J.A., Linette G.P., et al. The Her-2/neu gene and protein in breast cancer 2003: Biomarker and target of therapy. Oncologist 8 (2003) 307
29. Cobleigh M.A., Vogel C.L., Tripathy D., et al. Multinational study of the efficacy and safety of humanized anti-HER2 monoclonal antibody in women who have HER2-overexpressing metastatic breast cancer that has progressed after chemotherapy for metastatic disease. J Clin Oncol 17 (1999) 2639
30. Slamon D.J., Leyland-Jones B., Shak S., et al. Use of chemotherapy plus a monoclonal antibody against HER2 for metastatic breast cancer that overexpresses HER2. N Engl J Med 344 (2001) 783
31. Tripathy D., Slamon D.J., Cobleigh M., et al. Safety of treatment of metastatic breast cancer with trastuzumab beyond disease progression. J Clin Oncol 22 (2004) 1063
32. Banks A.S., Davis S.M., Bates S.H., et al. Activation of downstream signals by the long form of the leptin receptor. J Biol Chem 275 (2000) 14563
33. Sweeney G. Leptin signaling. Cell Signal 14 (2002) 655
34. Shida D., Kitayama J., Mori K., et al. Transactivation of epidermal growth factor receptor is involved in leptin-induced activation of janus-activated kinase 2 and extracellular signal-regulated kinase 1/2 in human gastric cancer cells. Cancer Res 65 (2005) 9159
35. Linnekin D., Mou S., Deberry C.S., et al. Stem cell factor, the JAK-STAT pathway and signal transduction. Leuk Lymphoma 27 (1997) 439
36. Walker F., Kato A., Gonez L.J., et al. Activation of the Ras/mitogen-activated protein kinase pathway by kinase-defective epidermal growth factor receptors results in cell survival but not proliferation. Mol Cell Biol 18 (1998) 7192
37. Revillion F., Charlier M., Lhotellier V., et al. Messenger RNA expression of leptin and leptin receptors and their prognostic value in 322 human primary breast cancers. Clin Cancer Res 12 (2006) 2088
38. Miyoshi Y., Funahashi T., Tanaka S., et al. High expression of leptin receptor mRNA in breast cancer tissue predicts poor prognosis for patients with high, but not low, serum leptin levels. Int J Cancer 118 (2006) 1414
39. Tessitore L., Vizio B., Jenkins O., et al. Leptin expression in colorectal and breast cancer patients. Int J Mol Med 5 (2000) 421
40. Ozet A., Arpaci F., Yilmaz M.I., et al. Effects of tamoxifen on the serum leptin level in patients with breast cancer. Jpn J Clin Oncol 31 (2001) 424
41. Chen D.C., Chung Y.F., Yeh Y.T., et al. Serum adiponectin and leptin levels in Taiwanese breast cancer patients. Cancer Lett 237 (2006) 109
42. Piiper A., and Zeuzem S. Receptor tyrosine kinases are signaling intermediates of G protein-coupled receptors. Curr Pharm Des 10 (2004) 3539
43. Natarajan K., and Berk B.C. Crosstalk co-regulation mechanisms of G protein-coupled receptors and receptor tyrosine kinases. Methods Mol Biol 332 (2006) 51
44. Qiu Y., Ravi L., and Kung H.J. Requirement of ErbB2 for signaling by interleukin-6 in prostate carcinoma cells. Nature 393 (1998) 83
45. Yamauchi T., Ueki K., Tobe K., et al. Growth hormone-induced tyrosine phosphorylation of EGF receptor as an essential element leading to MAP kinase activation and gene expression. Endocr J 45 Suppl (1998) S27
46. Yamauchi T., Yamauchi N., Ueki K., et al. Constitutive tyrosine phosphorylation of ErbB-2 via Jak2 by autocrine secretion of prolactin in human breast cancer. J Biol Chem 275 (2000) 33937
47. Huang Y., Li X., Jiang J., and Frank S.J. Prolactin modulates phosphorylation, signaling and trafficking of epidermal growth factor receptor in human T47D breast cancer cells. Oncogene 25 (2006) 7565
48. Ogunwobi O., Mutungi G., and Beales I.L. Leptin stimulates proliferation and inhibits apoptosis in Barrett's esophageal adenocarcinoma cells by cyclooxygenase-2-dependent, prostaglandin-E2-mediated transactivation of the epidermal growth factor receptor and c-Jun NH2-terminal kinase activation. Endocrinology 147 (2006) 4505
49. Eisenberg A., Biener E., Charlier M., et al. Transactivation of erbB2 by short and long isoforms of leptin receptors. FEBS Lett 565 (2004) 139
50. Garofalo C., Sisci D., and Surmacz E. Leptin interferes with the effects of the antiestrogen ICI 182,780 in MCF-7 breast cancer cells. Clin Cancer Res 10 (2004) 6466
51. Gschwind A., Prenzel N., and Ullrich A. Lysophosphatidic acid-induced squamous cell carcinoma cell proliferation and motility involves epidermal growth factor receptor signal transactivation. Cancer Res 62 (2002) 6329
52. Shida D., Kitayama J., Yamaguchi H., et al. Lysophospholipids transactivate HER2/neu (erbB-2) in human gastric cancer cells. Biochem Biophys Res Commun 327 (2005) 907
53. Mauro L., Catalano S., Bossi G., et al. Evidences that leptin up-regulates E-cadherin expression in breast cancer: Effects on tumor growth and progression. Cancer Res 67 (2007) 3412
54. Ray A., Nkhata K.J., and Cleary M.P. Effects of leptin on human breast cancer cell lines in relationship to estrogen receptor and HER2 status. Int J Oncol 30 (2007) 1499